Sep 11 |
GSK discontinues herpes vaccine; Roivant launches new ‘vant’ around hypertension drug
|
Sep 11 |
Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval
|
Sep 10 |
16 new GLP-1 weight-loss drugs could be launched by 2029: report
|
Sep 10 |
Top Stock Reports for Visa, AbbVie & Anheuser-Busch
|
Sep 10 |
EASD24: Eli Lilly releases Phase III data for once-weekly insulin in diabetes
|
Sep 10 |
Eli Lilly Says Efsitora Effective in Adults With Type 1 or 2 Diabetes in Phase 3 Trials
|
Sep 10 |
EASD 2024: Mazdutide improves cardiometabolic function in overweight patients
|
Sep 10 |
With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes
|
Sep 10 |
EASD 2024: Cardiovascular and inflammatory markers reduce after orforglipron treatment
|
Sep 10 |
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
|